Are IUDs superior emergency contraception?
Evidence suggests that intrauterine devices inserted within 5 days of unprotected intercourse are a safe, effective means of preventing unwanted pregnancy.
Almost 100% of IUD users overall did not become pregnant following unprotected sex when the device was inserted post-coitus.
Barriers to use include initial cost, lack of awareness among physicians and patients, and current insertion practices.
Intrauterine devices (IUDs) can be a safe, effective, and cost-effective option for emergency contraception, according to a systematic review of 42 English and Chinese studies.
The studies, involving approximately 7,000 women, were conducted between 1979 and 2011 in 6 countries and involved 8 types of IUDs. Time from unprotected sex to IUD insertion ranged from 2 to 10 or more days, but, for the majority of women, it occurred within the recommended 5 days.
The review provides clear evidence that IUDs are a highly effective method of emergency contraception: nearly 100% of users overall did not become pregnant after unprotected sex when an IUD was inserted post-coitus. Pregnancy rate (excluding 1 outlier study) was 0.09%. Conversely, the authors write, failure rates are at least 10 to 20 times higher with the various emergency contraceptive pills. The findings were published online May 8 in Human Reproduction.
Major advantages of copper IUDs is that, once inserted, they can be left in place as ongoing contraception for 10 years or more; further, their efficacy is unaffected by body mass index (BMI).
However, a recent study (Obstet Gynecol. 2012;119[2 Part1]:220-226) reports that use of copper IUDs for emergency contraception is hampered by the initial cost of the device, lack of awareness among physicians and patients, and current insertion practices: 93% of clinicians require 2 or more office visits for IUD insertion. Without same-day insertion, IUDs cannot compete with contraceptive pills, which can be obtained from the local pharmacy.
Read other articles in this issue of Special Delivery
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More
Barriers in seeking pelvic floor disorder treatment among ethnic minorities
May 8th 2024A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Read More
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More
